

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.19816961 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 4.19816961 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.17699870 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 4.17699870 |
| 5 | aldehyde catabolic process (GO:0046185) | 3.88295705 |
| 6 | signal peptide processing (GO:0006465) | 3.83691348 |
| 7 | cysteine metabolic process (GO:0006534) | 3.78074610 |
| 8 | Golgi transport vesicle coating (GO:0048200) | 3.72714857 |
| 9 | COPI coating of Golgi vesicle (GO:0048205) | 3.72714857 |
| 10 | intestinal cholesterol absorption (GO:0030299) | 3.61281902 |
| 11 | aromatic amino acid family catabolic process (GO:0009074) | 3.48397727 |
| 12 | proteasome assembly (GO:0043248) | 3.39593300 |
| 13 | protein maturation by protein folding (GO:0022417) | 3.38306777 |
| 14 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.37926578 |
| 15 | GDP-mannose metabolic process (GO:0019673) | 3.36239890 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.32544182 |
| 17 | regulation of mitochondrial translation (GO:0070129) | 3.25259406 |
| 18 | lysine metabolic process (GO:0006553) | 3.18638732 |
| 19 | lysine catabolic process (GO:0006554) | 3.18638732 |
| 20 | oxaloacetate metabolic process (GO:0006107) | 3.14858375 |
| 21 | intestinal absorption (GO:0050892) | 3.13669197 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 3.12573338 |
| 23 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.10745491 |
| 24 | ATP synthesis coupled proton transport (GO:0015986) | 3.10745491 |
| 25 | regulation of cholesterol esterification (GO:0010872) | 3.08368964 |
| 26 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.07490789 |
| 27 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.07490789 |
| 28 | neutrophil activation involved in immune response (GO:0002283) | 3.07479858 |
| 29 | alpha-linolenic acid metabolic process (GO:0036109) | 3.06036865 |
| 30 | valine metabolic process (GO:0006573) | 3.05220332 |
| 31 | NADH metabolic process (GO:0006734) | 3.04743680 |
| 32 | regulation of oxidative phosphorylation (GO:0002082) | 3.03357968 |
| 33 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.00657135 |
| 34 | branched-chain amino acid catabolic process (GO:0009083) | 2.98727802 |
| 35 | bile acid biosynthetic process (GO:0006699) | 2.94382321 |
| 36 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.94144070 |
| 37 | glyoxylate metabolic process (GO:0046487) | 2.91733359 |
| 38 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.88767008 |
| 39 | response to misfolded protein (GO:0051788) | 2.86713472 |
| 40 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.86433237 |
| 41 | tryptophan metabolic process (GO:0006568) | 2.85399031 |
| 42 | cotranslational protein targeting to membrane (GO:0006613) | 2.85155603 |
| 43 | protein targeting to ER (GO:0045047) | 2.82309080 |
| 44 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.80520186 |
| 45 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.80520186 |
| 46 | disruption of cells of other organism (GO:0044364) | 2.79984846 |
| 47 | killing of cells of other organism (GO:0031640) | 2.79984846 |
| 48 | oxidative phosphorylation (GO:0006119) | 2.79969735 |
| 49 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.79554285 |
| 50 | cofactor catabolic process (GO:0051187) | 2.79298118 |
| 51 | branched-chain amino acid metabolic process (GO:0009081) | 2.79151791 |
| 52 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.78687166 |
| 53 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.78326077 |
| 54 | protein localization to endoplasmic reticulum (GO:0070972) | 2.77482641 |
| 55 | protein-lipid complex remodeling (GO:0034368) | 2.76840171 |
| 56 | macromolecular complex remodeling (GO:0034367) | 2.76840171 |
| 57 | plasma lipoprotein particle remodeling (GO:0034369) | 2.76840171 |
| 58 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.76180651 |
| 59 | tryptophan catabolic process (GO:0006569) | 2.76163196 |
| 60 | indole-containing compound catabolic process (GO:0042436) | 2.76163196 |
| 61 | indolalkylamine catabolic process (GO:0046218) | 2.76163196 |
| 62 | glycosphingolipid catabolic process (GO:0046479) | 2.75933876 |
| 63 | coenzyme catabolic process (GO:0009109) | 2.75932419 |
| 64 | high-density lipoprotein particle remodeling (GO:0034375) | 2.74734763 |
| 65 | drug transmembrane transport (GO:0006855) | 2.71853592 |
| 66 | serine family amino acid metabolic process (GO:0009069) | 2.69493671 |
| 67 | regulation of triglyceride catabolic process (GO:0010896) | 2.69434107 |
| 68 | protein carboxylation (GO:0018214) | 2.69073846 |
| 69 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.69073846 |
| 70 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.68689124 |
| 71 | ribosomal small subunit assembly (GO:0000028) | 2.68436586 |
| 72 | aromatic amino acid family metabolic process (GO:0009072) | 2.68197349 |
| 73 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.67745397 |
| 74 | protein deneddylation (GO:0000338) | 2.67160736 |
| 75 | response to nitrosative stress (GO:0051409) | 2.65718379 |
| 76 | homocysteine metabolic process (GO:0050667) | 2.65491838 |
| 77 | rRNA modification (GO:0000154) | 2.65382097 |
| 78 | amino acid salvage (GO:0043102) | 2.65307773 |
| 79 | L-methionine salvage (GO:0071267) | 2.65307773 |
| 80 | L-methionine biosynthetic process (GO:0071265) | 2.65307773 |
| 81 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.64796245 |
| 82 | serine family amino acid biosynthetic process (GO:0009070) | 2.64615172 |
| 83 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.63765529 |
| 84 | kynurenine metabolic process (GO:0070189) | 2.63234955 |
| 85 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.60201898 |
| 86 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.60049796 |
| 87 | negative regulation of ligase activity (GO:0051352) | 2.60049796 |
| 88 | glycolipid catabolic process (GO:0019377) | 2.59848075 |
| 89 | bile acid and bile salt transport (GO:0015721) | 2.59650312 |
| 90 | drug transport (GO:0015893) | 2.58658170 |
| 91 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.58134054 |
| 92 | proline biosynthetic process (GO:0006561) | 2.57930973 |
| 93 | sulfur amino acid metabolic process (GO:0000096) | 2.57914556 |
| 94 | regulation of superoxide anion generation (GO:0032928) | 2.56992190 |
| 95 | urea metabolic process (GO:0019627) | 2.56860499 |
| 96 | urea cycle (GO:0000050) | 2.56860499 |
| 97 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.56591509 |
| 98 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.56591509 |
| 99 | bile acid metabolic process (GO:0008206) | 2.56262512 |
| 100 | glycine metabolic process (GO:0006544) | 2.56037077 |
| 101 | tyrosine metabolic process (GO:0006570) | 2.55888319 |
| 102 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.55760634 |
| 103 | urate metabolic process (GO:0046415) | 2.55025535 |
| 104 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.54765252 |
| 105 | alpha-amino acid catabolic process (GO:1901606) | 2.54482470 |
| 106 | pentose-phosphate shunt (GO:0006098) | 2.53947586 |
| 107 | phospholipid efflux (GO:0033700) | 2.53802479 |
| 108 | response to peptidoglycan (GO:0032494) | 2.53275515 |
| 109 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.53101364 |
| 110 | cellular ketone body metabolic process (GO:0046950) | 2.52906972 |
| 111 | cullin deneddylation (GO:0010388) | 2.52780095 |
| 112 | DNA deamination (GO:0045006) | 2.52632449 |
| 113 | COPII vesicle coating (GO:0048208) | 2.52146636 |
| 114 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.52001925 |
| 115 | low-density lipoprotein particle remodeling (GO:0034374) | 2.51813819 |
| 116 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.51627550 |
| 117 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.51550329 |
| 118 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.51550329 |
| 119 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.51550329 |
| 120 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.51087937 |
| 121 | proline metabolic process (GO:0006560) | 2.51015339 |
| 122 | tricarboxylic acid cycle (GO:0006099) | 2.50026546 |
| 123 | regulation of metalloenzyme activity (GO:0048552) | 2.49711086 |
| 124 | flavonoid metabolic process (GO:0009812) | 2.49666858 |
| 125 | heme biosynthetic process (GO:0006783) | 2.48336169 |
| 126 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.47638171 |
| 127 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.47638171 |
| 128 | negative regulation of interleukin-12 production (GO:0032695) | 2.46392018 |
| 129 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.42040056 |
| 130 | rRNA methylation (GO:0031167) | 2.41619500 |
| 131 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.41341629 |
| 132 | NIK/NF-kappaB signaling (GO:0038061) | 2.40985680 |
| 133 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.38856411 |
| 134 | ribosomal small subunit biogenesis (GO:0042274) | 2.37512334 |
| 135 | respiratory electron transport chain (GO:0022904) | 2.37310687 |
| 136 | protein targeting to mitochondrion (GO:0006626) | 2.34930448 |
| 137 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.34048665 |
| 138 | immunoglobulin mediated immune response (GO:0016064) | 2.33004800 |
| 139 | electron transport chain (GO:0022900) | 2.31367341 |
| 140 | ribosome biogenesis (GO:0042254) | 2.28950465 |
| 141 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.26333532 |
| 142 | fructose metabolic process (GO:0006000) | 2.25903930 |
| 143 | chaperone-mediated protein transport (GO:0072321) | 2.25824110 |
| 144 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.24849389 |
| 145 | ceramide catabolic process (GO:0046514) | 2.24774111 |
| 146 | negative regulation of cell killing (GO:0031342) | 2.22756958 |
| 147 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.22756958 |
| 148 | ribosome assembly (GO:0042255) | 2.22498191 |
| 149 | purine nucleotide salvage (GO:0032261) | 2.21691538 |
| 150 | formation of translation preinitiation complex (GO:0001731) | 2.21407787 |
| 151 | regulation of T cell tolerance induction (GO:0002664) | 2.20190442 |
| 152 | NADPH regeneration (GO:0006740) | 2.19020414 |
| 153 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.18902036 |
| 154 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.17779306 |
| 155 | regulation of chronic inflammatory response (GO:0002676) | 2.17490519 |
| 156 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.15683948 |
| 157 | positive regulation of ligase activity (GO:0051351) | 2.15059409 |
| 158 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.13855551 |
| 159 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.12443832 |
| 160 | positive regulation of cell cycle arrest (GO:0071158) | 2.10304365 |
| 161 | respiratory chain complex IV assembly (GO:0008535) | 2.09731534 |
| 162 | detection of bacterium (GO:0016045) | 2.09351455 |
| 163 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.09002448 |
| 164 | establishment of protein localization to mitochondrion (GO:0072655) | 2.08688354 |
| 165 | detection of other organism (GO:0098543) | 2.08665143 |
| 166 | pinocytosis (GO:0006907) | 2.08460001 |
| 167 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.07959633 |
| 168 | termination of RNA polymerase III transcription (GO:0006386) | 2.07959633 |
| 169 | modulation by symbiont of host defense response (GO:0052031) | 2.07897537 |
| 170 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.07897537 |
| 171 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.07897537 |
| 172 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.07897537 |
| 173 | modulation by symbiont of host immune response (GO:0052553) | 2.07897537 |
| 174 | positive regulation by symbiont of host defense response (GO:0052509) | 2.07897537 |
| 175 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.07372473 |
| 176 | protein localization to mitochondrion (GO:0070585) | 2.06839963 |
| 177 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.06831490 |
| 178 | regulation of cellular amine metabolic process (GO:0033238) | 2.06106998 |
| 179 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.05369073 |
| 180 | regulation of translation in response to stress (GO:0043555) | 2.04319448 |
| 181 | respiratory burst (GO:0045730) | 2.03849784 |
| 182 | nucleotide salvage (GO:0043173) | 2.02741828 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.85055956 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.49063008 |
| 3 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.43139446 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.31224538 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.21417745 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.10171424 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.05063119 |
| 8 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.03927703 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.90468801 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.89670411 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.87089167 |
| 12 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.80472166 |
| 13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.79641700 |
| 14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.76400638 |
| 15 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.75989161 |
| 16 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.74826123 |
| 17 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.50551301 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.46632418 |
| 19 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.45649575 |
| 20 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.25533731 |
| 21 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.19269706 |
| 22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.16792888 |
| 23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.16503026 |
| 24 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.10663845 |
| 25 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.03760748 |
| 26 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.96069622 |
| 27 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.93253822 |
| 28 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.90730462 |
| 29 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.89367364 |
| 30 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.87561478 |
| 31 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.86743061 |
| 32 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.85353447 |
| 33 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82571132 |
| 34 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.76179456 |
| 35 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.73243310 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.71875050 |
| 37 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.71834574 |
| 38 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.68818402 |
| 39 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.67695767 |
| 40 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.66534183 |
| 41 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.65143830 |
| 42 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.63871707 |
| 43 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.58279380 |
| 44 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.55814370 |
| 45 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.55147124 |
| 46 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.54820644 |
| 47 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.53450823 |
| 48 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.52632330 |
| 49 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.51859700 |
| 50 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51497305 |
| 51 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.49761939 |
| 52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48481662 |
| 53 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.47462725 |
| 54 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.46174410 |
| 55 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.44957824 |
| 56 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.44765464 |
| 57 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44741447 |
| 58 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.42719777 |
| 59 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.37837419 |
| 60 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.37063113 |
| 61 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.33053839 |
| 62 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.32814198 |
| 63 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32239874 |
| 64 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.32202816 |
| 65 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.31834998 |
| 66 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.31469072 |
| 67 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30794450 |
| 68 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.29770476 |
| 69 | MYC_22102868_ChIP-Seq_BL_Human | 1.26664388 |
| 70 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.26047186 |
| 71 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.24319862 |
| 72 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23752198 |
| 73 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.21115663 |
| 74 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.20815811 |
| 75 | MAF_26560356_Chip-Seq_TH2_Human | 1.20789783 |
| 76 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.20615377 |
| 77 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.19734782 |
| 78 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.19613498 |
| 79 | MAF_26560356_Chip-Seq_TH1_Human | 1.18121871 |
| 80 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.15722885 |
| 81 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.15267829 |
| 82 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.14266058 |
| 83 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.13958788 |
| 84 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.12720639 |
| 85 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.12564442 |
| 86 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.12102215 |
| 87 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.11352923 |
| 88 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.09563848 |
| 89 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.09271717 |
| 90 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08940325 |
| 91 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.08921022 |
| 92 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.08731492 |
| 93 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.08118880 |
| 94 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.07717052 |
| 95 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.06561938 |
| 96 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.05872930 |
| 97 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.05680151 |
| 98 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.05451091 |
| 99 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.04995607 |
| 100 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.04347207 |
| 101 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.03618953 |
| 102 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.03419403 |
| 103 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03009302 |
| 104 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.01778072 |
| 105 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.00969329 |
| 106 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.00945624 |
| 107 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.99927379 |
| 108 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.98637461 |
| 109 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.96166989 |
| 110 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95862765 |
| 111 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95309338 |
| 112 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.94451975 |
| 113 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.94363479 |
| 114 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.94317912 |
| 115 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.93892026 |
| 116 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93819443 |
| 117 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.93802030 |
| 118 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.93137956 |
| 119 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.91165777 |
| 120 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.90463783 |
| 121 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89646128 |
| 122 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.89595583 |
| 123 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.88700605 |
| 124 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.88684086 |
| 125 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85459980 |
| 126 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84975334 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.72963820 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.75256823 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 4.27203335 |
| 4 | MP0005365_abnormal_bile_salt | 4.10831540 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.93431160 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.59255137 |
| 7 | MP0005451_abnormal_body_composition | 3.15035771 |
| 8 | MP0001666_abnormal_nutrient_absorption | 3.02180837 |
| 9 | MP0005083_abnormal_biliary_tract | 2.37739041 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.30518835 |
| 11 | MP0005332_abnormal_amino_acid | 2.28684473 |
| 12 | MP0003195_calcinosis | 2.25955811 |
| 13 | MP0003186_abnormal_redox_activity | 2.24277025 |
| 14 | MP0003252_abnormal_bile_duct | 2.10196292 |
| 15 | MP0009840_abnormal_foam_cell | 2.00524949 |
| 16 | MP0001764_abnormal_homeostasis | 1.96406559 |
| 17 | MP0005084_abnormal_gallbladder_morpholo | 1.83423637 |
| 18 | MP0009785_altered_susceptibility_to | 1.83337121 |
| 19 | MP0001790_abnormal_immune_system | 1.81528344 |
| 20 | MP0005387_immune_system_phenotype | 1.81528344 |
| 21 | MP0003724_increased_susceptibility_to | 1.79788053 |
| 22 | MP0003436_decreased_susceptibility_to | 1.78082954 |
| 23 | MP0008260_abnormal_autophagy | 1.76657959 |
| 24 | MP0006036_abnormal_mitochondrial_physio | 1.73187005 |
| 25 | MP0005636_abnormal_mineral_homeostasis | 1.73120654 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.72495829 |
| 27 | MP0000013_abnormal_adipose_tissue | 1.71499259 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.71047170 |
| 29 | MP0000609_abnormal_liver_physiology | 1.68088206 |
| 30 | MP0005671_abnormal_response_to | 1.67885535 |
| 31 | MP0005220_abnormal_exocrine_pancreas | 1.64517910 |
| 32 | MP0003656_abnormal_erythrocyte_physiolo | 1.56474083 |
| 33 | MP0004043_abnormal_pH_regulation | 1.52503058 |
| 34 | MP0004147_increased_porphyrin_level | 1.52315946 |
| 35 | MP0003866_abnormal_defecation | 1.50269786 |
| 36 | MP0001835_abnormal_antigen_presentation | 1.44773216 |
| 37 | MP0002877_abnormal_melanocyte_morpholog | 1.39447583 |
| 38 | MP0001533_abnormal_skeleton_physiology | 1.39432843 |
| 39 | MP0008469_abnormal_protein_level | 1.38738934 |
| 40 | MP0000343_altered_response_to | 1.37019498 |
| 41 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.36470699 |
| 42 | MP0003191_abnormal_cellular_cholesterol | 1.36091965 |
| 43 | MP0002118_abnormal_lipid_homeostasis | 1.34208732 |
| 44 | MP0000749_muscle_degeneration | 1.33715025 |
| 45 | MP0005025_abnormal_response_to | 1.33459963 |
| 46 | MP0003868_abnormal_feces_composition | 1.32882882 |
| 47 | MP0003303_peritoneal_inflammation | 1.32634069 |
| 48 | MP0004019_abnormal_vitamin_homeostasis | 1.29869251 |
| 49 | MP0003693_abnormal_embryo_hatching | 1.29565834 |
| 50 | MP0002132_abnormal_respiratory_system | 1.27165979 |
| 51 | MP0002693_abnormal_pancreas_physiology | 1.27013188 |
| 52 | MP0002138_abnormal_hepatobiliary_system | 1.26850288 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.26583715 |
| 54 | MP0003183_abnormal_peptide_metabolism | 1.24492846 |
| 55 | MP0009379_abnormal_foot_pigmentation | 1.20074094 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.19280144 |
| 57 | MP0005408_hypopigmentation | 1.19087079 |
| 58 | MP0004264_abnormal_extraembryonic_tissu | 1.18301267 |
| 59 | MP0003763_abnormal_thymus_physiology | 1.18183983 |
| 60 | MP0001661_extended_life_span | 1.17848723 |
| 61 | MP0006035_abnormal_mitochondrial_morpho | 1.17373814 |
| 62 | MP0008058_abnormal_DNA_repair | 1.17050704 |
| 63 | MP0002277_abnormal_respiratory_mucosa | 1.14312309 |
| 64 | MP0004510_myositis | 1.14253936 |
| 65 | MP0002405_respiratory_system_inflammati | 1.13979240 |
| 66 | MP0010155_abnormal_intestine_physiology | 1.13854014 |
| 67 | MP0005464_abnormal_platelet_physiology | 1.13364434 |
| 68 | MP0003111_abnormal_nucleus_morphology | 1.12407421 |
| 69 | MP0005330_cardiomyopathy | 1.10769014 |
| 70 | MP0005058_abnormal_lysosome_morphology | 1.10078817 |
| 71 | MP0005000_abnormal_immune_tolerance | 1.09308759 |
| 72 | MP0009764_decreased_sensitivity_to | 1.08798376 |
| 73 | MP0002419_abnormal_innate_immunity | 1.08395514 |
| 74 | MP0004947_skin_inflammation | 1.07818336 |
| 75 | MP0000015_abnormal_ear_pigmentation | 1.07745851 |
| 76 | MP0001881_abnormal_mammary_gland | 1.07736574 |
| 77 | MP0010386_abnormal_urinary_bladder | 1.06858013 |
| 78 | MP0001800_abnormal_humoral_immune | 1.06588237 |
| 79 | MP0005310_abnormal_salivary_gland | 1.04197537 |
| 80 | MP0002078_abnormal_glucose_homeostasis | 1.02185795 |
| 81 | MP0001756_abnormal_urination | 1.02135495 |
| 82 | MP0000750_abnormal_muscle_regeneration | 1.02040809 |
| 83 | MP0002148_abnormal_hypersensitivity_rea | 1.01486848 |
| 84 | MP0002837_dystrophic_cardiac_calcinosis | 1.00905096 |
| 85 | MP0000490_abnormal_crypts_of | 1.00827436 |
| 86 | MP0004381_abnormal_hair_follicle | 1.00445366 |
| 87 | MP0000747_muscle_weakness | 1.00428496 |
| 88 | MP0010352_gastrointestinal_tract_polyps | 1.00343497 |
| 89 | MP0009765_abnormal_xenobiotic_induced | 0.99775314 |
| 90 | MP0002723_abnormal_immune_serum | 0.99248233 |
| 91 | MP0003075_altered_response_to | 0.98541457 |
| 92 | MP0006054_spinal_hemorrhage | 0.98516618 |
| 93 | MP0000598_abnormal_liver_morphology | 0.98352779 |
| 94 | MP0000685_abnormal_immune_system | 0.98331265 |
| 95 | MP0009697_abnormal_copulation | 0.98293036 |
| 96 | MP0003786_premature_aging | 0.98291317 |
| 97 | MP0000604_amyloidosis | 0.97778003 |
| 98 | MP0005670_abnormal_white_adipose | 0.96505293 |
| 99 | MP0006082_CNS_inflammation | 0.95842006 |
| 100 | MP0003172_abnormal_lysosome_physiology | 0.95360747 |
| 101 | MP0002420_abnormal_adaptive_immunity | 0.95200978 |
| 102 | MP0001944_abnormal_pancreas_morphology | 0.93837443 |
| 103 | MP0001819_abnormal_immune_cell | 0.93505990 |
| 104 | MP0009763_increased_sensitivity_to | 0.93412177 |
| 105 | MP0010234_abnormal_vibrissa_follicle | 0.93160081 |
| 106 | MP0005165_increased_susceptibility_to | 0.92564711 |
| 107 | MP0009642_abnormal_blood_homeostasis | 0.92117701 |
| 108 | MP0002396_abnormal_hematopoietic_system | 0.91669452 |
| 109 | MP0001873_stomach_inflammation | 0.90669723 |
| 110 | MP0005166_decreased_susceptibility_to | 0.90276220 |
| 111 | MP0002876_abnormal_thyroid_physiology | 0.88628851 |
| 112 | MP0000858_altered_metastatic_potential | 0.88158831 |
| 113 | MP0005075_abnormal_melanosome_morpholog | 0.86970302 |
| 114 | MP0002452_abnormal_antigen_presenting | 0.86161964 |
| 115 | MP0008873_increased_physiological_sensi | 0.85765892 |
| 116 | MP0005376_homeostasis/metabolism_phenot | 0.85152042 |
| 117 | MP0003718_maternal_effect | 0.83842376 |
| 118 | MP0001853_heart_inflammation | 0.82724586 |
| 119 | MP0004782_abnormal_surfactant_physiolog | 0.81732158 |
| 120 | MP0002398_abnormal_bone_marrow | 0.80614797 |
| 121 | MP0000716_abnormal_immune_system | 0.80351676 |
| 122 | MP0002796_impaired_skin_barrier | 0.79878804 |
| 123 | MP0005266_abnormal_metabolism | 0.79474299 |
| 124 | MP0000689_abnormal_spleen_morphology | 0.78974149 |
| 125 | MP0002166_altered_tumor_susceptibility | 0.78543616 |
| 126 | MP0004957_abnormal_blastocyst_morpholog | 0.77152940 |
| 127 | MP0003646_muscle_fatigue | 0.77105521 |
| 128 | MP0002429_abnormal_blood_cell | 0.76217230 |
| 129 | MP0000313_abnormal_cell_death | 0.75748906 |
| 130 | MP0001663_abnormal_digestive_system | 0.74853763 |
| 131 | MP0000358_abnormal_cell_content/ | 0.74830657 |
| 132 | MP0003879_abnormal_hair_cell | 0.74301907 |
| 133 | MP0002136_abnormal_kidney_physiology | 0.74187776 |
| 134 | MP0002006_tumorigenesis | 0.74133689 |
| 135 | MP0002722_abnormal_immune_system | 0.73980307 |
| 136 | MP0003448_altered_tumor_morphology | 0.73927402 |
| 137 | MP0005535_abnormal_body_temperature | 0.72749612 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.57860820 |
| 2 | Generalized aminoaciduria (HP:0002909) | 3.96186771 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 3.81029583 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 3.69643876 |
| 5 | Hepatic necrosis (HP:0002605) | 3.64468570 |
| 6 | Hepatocellular necrosis (HP:0001404) | 3.52969461 |
| 7 | Acute necrotizing encephalopathy (HP:0006965) | 3.42913833 |
| 8 | Acute encephalopathy (HP:0006846) | 3.39641477 |
| 9 | Mitochondrial inheritance (HP:0001427) | 3.38497899 |
| 10 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.37903959 |
| 11 | Intrahepatic cholestasis (HP:0001406) | 3.35679163 |
| 12 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.35291135 |
| 13 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.32950402 |
| 14 | Ketosis (HP:0001946) | 3.23142601 |
| 15 | Lipid accumulation in hepatocytes (HP:0006561) | 3.20093692 |
| 16 | Xanthomatosis (HP:0000991) | 3.15349902 |
| 17 | Nausea (HP:0002018) | 3.14621195 |
| 18 | Hypoglycemic coma (HP:0001325) | 3.11403278 |
| 19 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.05364812 |
| 20 | Ketoacidosis (HP:0001993) | 3.04970891 |
| 21 | Cerebral edema (HP:0002181) | 3.04501142 |
| 22 | Increased CSF lactate (HP:0002490) | 3.02855457 |
| 23 | Abnormality of the intrinsic pathway (HP:0010989) | 2.87020176 |
| 24 | Increased hepatocellular lipid droplets (HP:0006565) | 2.86845098 |
| 25 | Fat malabsorption (HP:0002630) | 2.86654591 |
| 26 | Gout (HP:0001997) | 2.84915671 |
| 27 | Abnormality of macrophages (HP:0004311) | 2.84395545 |
| 28 | Recurrent abscess formation (HP:0002722) | 2.82003453 |
| 29 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.81004952 |
| 30 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.81004952 |
| 31 | Abnormality of glycolipid metabolism (HP:0010969) | 2.81004952 |
| 32 | Progressive macrocephaly (HP:0004481) | 2.79298768 |
| 33 | Vacuolated lymphocytes (HP:0001922) | 2.78433253 |
| 34 | Glycosuria (HP:0003076) | 2.73121885 |
| 35 | Abnormality of urine glucose concentration (HP:0011016) | 2.73121885 |
| 36 | Abnormality of the common coagulation pathway (HP:0010990) | 2.72255947 |
| 37 | Lethargy (HP:0001254) | 2.72249881 |
| 38 | Hyperammonemia (HP:0001987) | 2.71299469 |
| 39 | Conjugated hyperbilirubinemia (HP:0002908) | 2.70508662 |
| 40 | Increased muscle lipid content (HP:0009058) | 2.70150316 |
| 41 | Reduced antithrombin III activity (HP:0001976) | 2.69962851 |
| 42 | Myositis (HP:0100614) | 2.67767670 |
| 43 | Orchitis (HP:0100796) | 2.66536048 |
| 44 | Recurrent bacterial skin infections (HP:0005406) | 2.65316649 |
| 45 | Type I transferrin isoform profile (HP:0003642) | 2.65188486 |
| 46 | Ragged-red muscle fibers (HP:0003200) | 2.60848781 |
| 47 | Increased intramyocellular lipid droplets (HP:0012240) | 2.56357816 |
| 48 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.56042699 |
| 49 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.56042699 |
| 50 | Hyperbilirubinemia (HP:0002904) | 2.54723053 |
| 51 | Renal Fanconi syndrome (HP:0001994) | 2.53226315 |
| 52 | Deep venous thrombosis (HP:0002625) | 2.52446520 |
| 53 | CNS demyelination (HP:0007305) | 2.46522774 |
| 54 | Lactic acidosis (HP:0003128) | 2.46284901 |
| 55 | Metabolic acidosis (HP:0001942) | 2.46179734 |
| 56 | Symptomatic seizures (HP:0011145) | 2.45783411 |
| 57 | Testicular atrophy (HP:0000029) | 2.44927456 |
| 58 | Abnormality of placental membranes (HP:0011409) | 2.43302051 |
| 59 | Amniotic constriction ring (HP:0009775) | 2.43302051 |
| 60 | Abnormality of purine metabolism (HP:0004352) | 2.41386324 |
| 61 | Hyperlipoproteinemia (HP:0010980) | 2.39948434 |
| 62 | Rhabdomyolysis (HP:0003201) | 2.37775840 |
| 63 | Hepatosplenomegaly (HP:0001433) | 2.36653619 |
| 64 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.36341450 |
| 65 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.35327599 |
| 66 | Exertional dyspnea (HP:0002875) | 2.34237150 |
| 67 | Hyperphosphaturia (HP:0003109) | 2.34050825 |
| 68 | Systemic lupus erythematosus (HP:0002725) | 2.33792062 |
| 69 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.31383102 |
| 70 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.31383102 |
| 71 | Abnormal protein glycosylation (HP:0012346) | 2.31383102 |
| 72 | Abnormal glycosylation (HP:0012345) | 2.31383102 |
| 73 | Abnormality of nucleobase metabolism (HP:0010932) | 2.28365813 |
| 74 | Exercise intolerance (HP:0003546) | 2.27370532 |
| 75 | Petechiae (HP:0000967) | 2.26615129 |
| 76 | Steatorrhea (HP:0002570) | 2.26526784 |
| 77 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.26370766 |
| 78 | Dicarboxylic aciduria (HP:0003215) | 2.26370766 |
| 79 | Increased serum ferritin (HP:0003281) | 2.26278206 |
| 80 | Rough bone trabeculation (HP:0100670) | 2.26177694 |
| 81 | Vomiting (HP:0002013) | 2.25856416 |
| 82 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.24981801 |
| 83 | Optic neuritis (HP:0100653) | 2.24593627 |
| 84 | Retrobulbar optic neuritis (HP:0100654) | 2.24593627 |
| 85 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.24492830 |
| 86 | Hyperglycinuria (HP:0003108) | 2.23290271 |
| 87 | * Anorexia (HP:0002039) | 2.21971398 |
| 88 | Progressive external ophthalmoplegia (HP:0000590) | 2.21927921 |
| 89 | Late onset (HP:0003584) | 2.21174266 |
| 90 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.20586588 |
| 91 | 3-Methylglutaconic aciduria (HP:0003535) | 2.19191366 |
| 92 | Aplastic anemia (HP:0001915) | 2.19143283 |
| 93 | Hypoglycemic seizures (HP:0002173) | 2.17553897 |
| 94 | Brushfield spots (HP:0001088) | 2.15785994 |
| 95 | Increased serum lactate (HP:0002151) | 2.14445283 |
| 96 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.14327709 |
| 97 | Thrombocytosis (HP:0001894) | 2.13647501 |
| 98 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.12721262 |
| 99 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.12535860 |
| 100 | Abnormal gallbladder physiology (HP:0012438) | 2.12205443 |
| 101 | Cholecystitis (HP:0001082) | 2.12205443 |
| 102 | Respiratory failure (HP:0002878) | 2.12082391 |
| 103 | Delayed CNS myelination (HP:0002188) | 2.11122473 |
| 104 | Joint hemorrhage (HP:0005261) | 2.10397162 |
| 105 | Abnormality of glycine metabolism (HP:0010895) | 2.09050790 |
| 106 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.09050790 |
| 107 | Abnormality of glycolysis (HP:0004366) | 2.08092642 |
| 108 | Increased serum pyruvate (HP:0003542) | 2.08092642 |
| 109 | Hypolipoproteinemia (HP:0010981) | 2.07408407 |
| 110 | Malnutrition (HP:0004395) | 2.07053400 |
| 111 | Pancreatitis (HP:0001733) | 2.06543954 |
| 112 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.05864117 |
| 113 | Myopathic facies (HP:0002058) | 2.03911863 |
| 114 | Chronic obstructive pulmonary disease (HP:0006510) | 2.03176673 |
| 115 | Obstructive lung disease (HP:0006536) | 2.03176673 |
| 116 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.02324791 |
| 117 | Myocardial infarction (HP:0001658) | 2.01808080 |
| 118 | Abnormal trabecular bone morphology (HP:0100671) | 2.01353204 |
| 119 | Epiphyseal stippling (HP:0010655) | 2.00256971 |
| 120 | Complement deficiency (HP:0004431) | 2.00020659 |
| 121 | Proximal tubulopathy (HP:0000114) | 1.98940371 |
| 122 | Irritability (HP:0000737) | 1.98904409 |
| 123 | Hyperglycinemia (HP:0002154) | 1.98774399 |
| 124 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.98638300 |
| 125 | Respiratory difficulties (HP:0002880) | 1.97322639 |
| 126 | Nemaline bodies (HP:0003798) | 1.96740778 |
| 127 | Axonal loss (HP:0003447) | 1.93514176 |
| 128 | Abnormal number of erythroid precursors (HP:0012131) | 1.93430808 |
| 129 | Emotional lability (HP:0000712) | 1.93268874 |
| 130 | Eczematoid dermatitis (HP:0000976) | 1.91331995 |
| 131 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.90865162 |
| 132 | Progressive muscle weakness (HP:0003323) | 1.88702089 |
| 133 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.88498210 |
| 134 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.88498210 |
| 135 | Opisthotonus (HP:0002179) | 1.87451508 |
| 136 | Spastic diplegia (HP:0001264) | 1.85534559 |
| 137 | Oral leukoplakia (HP:0002745) | 1.85167869 |
| 138 | Abnormal pupillary function (HP:0007686) | 1.82125433 |
| 139 | Abnormality of iron homeostasis (HP:0011031) | 1.79793828 |
| 140 | Urticaria (HP:0001025) | 1.78845618 |
| 141 | Progressive neurologic deterioration (HP:0002344) | 1.78219899 |
| 142 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.78095697 |
| 143 | Recurrent skin infections (HP:0001581) | 1.77725323 |
| 144 | Abnormality of T cell physiology (HP:0011840) | 1.76995510 |
| 145 | Muscle fiber inclusion bodies (HP:0100299) | 1.75417832 |
| 146 | Trismus (HP:0000211) | 1.74629998 |
| 147 | Multiple enchondromatosis (HP:0005701) | 1.73478100 |
| 148 | Cholelithiasis (HP:0001081) | 1.72687582 |
| 149 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.72675818 |
| 150 | Encephalitis (HP:0002383) | 1.70748757 |
| 151 | Palpitations (HP:0001962) | 1.70170408 |
| 152 | Loss of speech (HP:0002371) | 1.68846180 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.02527420 |
| 2 | MST4 | 3.13999733 |
| 3 | ERN1 | 3.00279772 |
| 4 | NME2 | 2.97648173 |
| 5 | NME1 | 2.95298851 |
| 6 | MAPKAPK3 | 2.94252334 |
| 7 | CDK19 | 2.70859933 |
| 8 | MAP3K12 | 2.62590621 |
| 9 | FRK | 2.57073084 |
| 10 | VRK2 | 2.51966439 |
| 11 | STK16 | 2.43031796 |
| 12 | TESK2 | 2.37962358 |
| 13 | EIF2AK1 | 2.33859447 |
| 14 | GRK6 | 2.24004787 |
| 15 | KDR | 2.14986381 |
| 16 | EIF2AK3 | 2.10532562 |
| 17 | SRPK1 | 1.94687582 |
| 18 | PDK2 | 1.94017794 |
| 19 | ZAP70 | 1.85163824 |
| 20 | BUB1 | 1.81803438 |
| 21 | MAP4K1 | 1.71520705 |
| 22 | SIK3 | 1.68250845 |
| 23 | FLT3 | 1.64095908 |
| 24 | PIM2 | 1.62321469 |
| 25 | RIPK4 | 1.62233639 |
| 26 | TESK1 | 1.61912995 |
| 27 | TRIM28 | 1.54122035 |
| 28 | ACVR1B | 1.52470125 |
| 29 | TSSK6 | 1.50635724 |
| 30 | IRAK4 | 1.48607034 |
| 31 | DAPK1 | 1.47424314 |
| 32 | TYK2 | 1.45103980 |
| 33 | PASK | 1.42280829 |
| 34 | MST1R | 1.39538215 |
| 35 | MYLK | 1.36583356 |
| 36 | JAK3 | 1.36412537 |
| 37 | TAOK3 | 1.34445383 |
| 38 | TXK | 1.31605991 |
| 39 | EEF2K | 1.30770735 |
| 40 | IRAK3 | 1.30491648 |
| 41 | TLK1 | 1.29812784 |
| 42 | FGFR4 | 1.29739023 |
| 43 | SMG1 | 1.23584123 |
| 44 | TBK1 | 1.20200135 |
| 45 | MUSK | 1.17499171 |
| 46 | SIK1 | 1.17294455 |
| 47 | TAOK1 | 1.11602435 |
| 48 | TAOK2 | 1.11562595 |
| 49 | SYK | 1.06975680 |
| 50 | RPS6KB2 | 1.05444399 |
| 51 | MARK3 | 1.03764761 |
| 52 | LRRK2 | 1.00993627 |
| 53 | PRPF4B | 1.00745352 |
| 54 | MAP3K2 | 1.00344917 |
| 55 | MAP3K10 | 0.99718858 |
| 56 | BMPR1B | 0.96247646 |
| 57 | ARAF | 0.95641790 |
| 58 | EPHB1 | 0.93590347 |
| 59 | TGFBR1 | 0.90928343 |
| 60 | ABL2 | 0.90510911 |
| 61 | PTK6 | 0.90357325 |
| 62 | MAPK11 | 0.87196375 |
| 63 | BTK | 0.85854083 |
| 64 | CLK1 | 0.84208614 |
| 65 | TEC | 0.81350077 |
| 66 | ERBB4 | 0.81216489 |
| 67 | ILK | 0.79682405 |
| 68 | MAP3K14 | 0.78551575 |
| 69 | WEE1 | 0.78511976 |
| 70 | MAP3K8 | 0.77940482 |
| 71 | IKBKB | 0.77898350 |
| 72 | PLK4 | 0.76016695 |
| 73 | MAP2K2 | 0.75602139 |
| 74 | MAP3K1 | 0.75217520 |
| 75 | ITK | 0.74930758 |
| 76 | TRIB3 | 0.74074567 |
| 77 | FGR | 0.72814490 |
| 78 | LCK | 0.72370048 |
| 79 | PRKD2 | 0.72042157 |
| 80 | LYN | 0.71253898 |
| 81 | VRK1 | 0.69573218 |
| 82 | MAPK4 | 0.68354614 |
| 83 | CSK | 0.66539416 |
| 84 | KIT | 0.65908061 |
| 85 | PDPK1 | 0.65500455 |
| 86 | MAP3K3 | 0.64738074 |
| 87 | IKBKE | 0.63417895 |
| 88 | EPHA2 | 0.61331086 |
| 89 | CCNB1 | 0.60149400 |
| 90 | PIK3CG | 0.59161516 |
| 91 | SCYL2 | 0.58885040 |
| 92 | GRK7 | 0.57460539 |
| 93 | BLK | 0.56493522 |
| 94 | BMPR2 | 0.55431345 |
| 95 | CDK7 | 0.54809417 |
| 96 | PRKCI | 0.52896117 |
| 97 | CAMKK2 | 0.52766568 |
| 98 | MAP2K6 | 0.52566835 |
| 99 | PRKG2 | 0.52063965 |
| 100 | AKT3 | 0.51138992 |
| 101 | OBSCN | 0.50938837 |
| 102 | DAPK3 | 0.50765533 |
| 103 | BRAF | 0.49751325 |
| 104 | WNK3 | 0.49230352 |
| 105 | LIMK1 | 0.48788452 |
| 106 | PDK3 | 0.47301839 |
| 107 | PDK4 | 0.47301839 |
| 108 | MAP3K5 | 0.46979904 |
| 109 | PAK1 | 0.46596482 |
| 110 | PAK4 | 0.45468716 |
| 111 | TGFBR2 | 0.45413064 |
| 112 | INSRR | 0.44550157 |
| 113 | STK4 | 0.44429177 |
| 114 | AURKA | 0.44194903 |
| 115 | STK10 | 0.43566283 |
| 116 | ADRBK2 | 0.42857641 |
| 117 | PRKCD | 0.42316984 |
| 118 | TTN | 0.41828649 |
| 119 | MAPKAPK2 | 0.40591929 |
| 120 | JAK1 | 0.39488814 |
| 121 | PIM1 | 0.39148405 |
| 122 | KSR2 | 0.39064217 |
| 123 | PBK | 0.38616984 |
| 124 | MAP3K11 | 0.37617724 |
| 125 | CSNK2A2 | 0.37452135 |
| 126 | NEK1 | 0.36889122 |
| 127 | RAF1 | 0.36232293 |
| 128 | JAK2 | 0.35462813 |
| 129 | HCK | 0.35080396 |
| 130 | MAP2K3 | 0.34879806 |
| 131 | CSNK1G3 | 0.34684427 |
| 132 | MAP2K7 | 0.34425199 |
| 133 | CSNK2A1 | 0.34078819 |
| 134 | MAPK12 | 0.33926980 |
| 135 | IRAK2 | 0.33271540 |
| 136 | RPS6KB1 | 0.32990706 |
| 137 | MET | 0.32793642 |
| 138 | PHKG2 | 0.32646611 |
| 139 | PHKG1 | 0.32646611 |
| 140 | STK24 | 0.31749605 |
| 141 | MAPK15 | 0.30957215 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.86734530 |
| 2 | Protein export_Homo sapiens_hsa03060 | 2.85218323 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.75971752 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 2.53775709 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.44068527 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.23569856 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.16196698 |
| 8 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.05391539 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.05188485 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.02147661 |
| 11 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.99855059 |
| 12 | Ribosome_Homo sapiens_hsa03010 | 1.88231104 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.84540558 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 1.83341970 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.83124670 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.78677001 |
| 17 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.77641122 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.77442096 |
| 19 | Parkinsons disease_Homo sapiens_hsa05012 | 1.70828500 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.68370919 |
| 21 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.67978547 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.63704091 |
| 23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.63157121 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.62006701 |
| 25 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.59439323 |
| 26 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.57596073 |
| 27 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.56727876 |
| 28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.50473973 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.50380653 |
| 30 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.47888225 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.47058785 |
| 32 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.46133150 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.42792492 |
| 34 | Base excision repair_Homo sapiens_hsa03410 | 1.38824599 |
| 35 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.35695190 |
| 36 | Carbon metabolism_Homo sapiens_hsa01200 | 1.35582149 |
| 37 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.35069489 |
| 38 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.30606321 |
| 39 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.29786502 |
| 40 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.29458705 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.29191248 |
| 42 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.27291834 |
| 43 | Alzheimers disease_Homo sapiens_hsa05010 | 1.26096878 |
| 44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.24750601 |
| 45 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.24125250 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.23629597 |
| 47 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.22988842 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.20618502 |
| 49 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.19920961 |
| 50 | Galactose metabolism_Homo sapiens_hsa00052 | 1.17611715 |
| 51 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.15051985 |
| 52 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.14396015 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 1.11659450 |
| 54 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.09844327 |
| 55 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.02181938 |
| 56 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.00506522 |
| 57 | RNA polymerase_Homo sapiens_hsa03020 | 0.98642276 |
| 58 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.95599830 |
| 59 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.93370891 |
| 60 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.92500652 |
| 61 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.91534499 |
| 62 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90229154 |
| 63 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.89828414 |
| 64 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.89621085 |
| 65 | Huntingtons disease_Homo sapiens_hsa05016 | 0.88105450 |
| 66 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.88083697 |
| 67 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.87400691 |
| 68 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.86320119 |
| 69 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.84864601 |
| 70 | Allograft rejection_Homo sapiens_hsa05330 | 0.83518267 |
| 71 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.82841189 |
| 72 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.81807886 |
| 73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.81672257 |
| 74 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.81444445 |
| 75 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.81393113 |
| 76 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.80634710 |
| 77 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.80384167 |
| 78 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.79613138 |
| 79 | Mineral absorption_Homo sapiens_hsa04978 | 0.79592283 |
| 80 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.79427739 |
| 81 | Leishmaniasis_Homo sapiens_hsa05140 | 0.79261879 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78935110 |
| 83 | Asthma_Homo sapiens_hsa05310 | 0.78505579 |
| 84 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.78408824 |
| 85 | Other glycan degradation_Homo sapiens_hsa00511 | 0.77129375 |
| 86 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.76292243 |
| 87 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.75336379 |
| 88 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.75090785 |
| 89 | Spliceosome_Homo sapiens_hsa03040 | 0.73428150 |
| 90 | Shigellosis_Homo sapiens_hsa05131 | 0.71066022 |
| 91 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.70289911 |
| 92 | Pertussis_Homo sapiens_hsa05133 | 0.70108513 |
| 93 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.69620454 |
| 94 | Viral myocarditis_Homo sapiens_hsa05416 | 0.68833759 |
| 95 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.68579245 |
| 96 | Tuberculosis_Homo sapiens_hsa05152 | 0.67713623 |
| 97 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66784821 |
| 98 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.66433111 |
| 99 | DNA replication_Homo sapiens_hsa03030 | 0.65731408 |
| 100 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.65374697 |
| 101 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.63006522 |
| 102 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62795108 |
| 103 | ABC transporters_Homo sapiens_hsa02010 | 0.62779158 |
| 104 | Legionellosis_Homo sapiens_hsa05134 | 0.62352470 |
| 105 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61743380 |
| 106 | Measles_Homo sapiens_hsa05162 | 0.61558525 |
| 107 | Retinol metabolism_Homo sapiens_hsa00830 | 0.61548856 |
| 108 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.61450584 |
| 109 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.59634953 |
| 110 | Salmonella infection_Homo sapiens_hsa05132 | 0.59593308 |
| 111 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.58732473 |
| 112 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.57198133 |
| 113 | Apoptosis_Homo sapiens_hsa04210 | 0.56263131 |
| 114 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.52896635 |
| 115 | Mismatch repair_Homo sapiens_hsa03430 | 0.51475542 |
| 116 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.51137096 |
| 117 | Bile secretion_Homo sapiens_hsa04976 | 0.47413203 |
| 118 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.42648674 |
| 119 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41582712 |
| 120 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.38384126 |
| 121 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.37885111 |
| 122 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.36923764 |
| 123 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.36121686 |
| 124 | Lysosome_Homo sapiens_hsa04142 | 0.36101366 |
| 125 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.33719872 |
| 126 | Phagosome_Homo sapiens_hsa04145 | 0.33676942 |
| 127 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.31422756 |
| 128 | Purine metabolism_Homo sapiens_hsa00230 | 0.26015040 |

